# Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.

> **NCT02376218** · NA · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 10 (actual)

## Conditions studied

- Pulmonary Surgical Procedures

## Interventions

- **DRUG:** Hypertonic 50% dextrose pleurodesis

## Key facts

- **NCT ID:** NCT02376218
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376218, "Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02376218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*